Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations-Reference-Cited by-同舟云学术

Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations

Published:2024-07-30 Issue:1 Volume:14 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Gordon Jaymeson^ORCID,Bravo-Perez Carlos,Guarnera Luca,Unlu Serhan,Kawashima Naomi,Ahmed Arooj,Haddad Christopher,Kubota Yasuo,Nautiyal Ishani,Ullah Fauzia^ORCID,Dima Danai^ORCID,Williams Nakisha D.,Kewan Tariq,Bahaj Waled,Carraway Hetty E.^ORCID,Yang Chao-Yie^ORCID,Gurnari Carmelo^ORCID,Visconte Valeria^ORCID,Maciejewski Jaroslaw P.

Funder

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41408-024-01104-9.pdf

Reference15 articles.

1. Kazi JU, Rönnstrand L. FMS-like tyrosine kinase 3/FLT3: from basic science to clinical implications. Physiol Rev. 2019;99:1433–66.

2. Daver N, Schlenk RF, Russell NH, Levis MJ. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019;33:299–312.

3. Bacher U, Haferlach C, Kern W, Haferlach T, Schnittger S. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients. Blood. 2008;111:2527–37.

4. Clark JJ, Cools J, Curley DP, Yu J-C, Lokker NA, Giese NA, et al. Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518. Blood. 2004;104:2867–72.

5. Ge S-S, Qiu Q-C, Dai H-P, Shen X-D, Wu T-M, Du J-H, et al. Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. Br J Haematol. 2023;202:539–49.